Yunnan Green A Biological Project Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Yunnan Green A Biological Project Co., Ltd. - overview
Established
1997
Location
Kunming, Yunnan, China
Primary Industry
Food
About
Yunnan Green A Biological Project Co. , Ltd. focuses on the cultivation and production of high-quality spirulina, catering to health-focused markets with products that promote nutritional benefits and wellness. Founded in 1997 and headquartered in Kunming, China, Yunnan Green A Biological Project Co.
, Ltd. specializes in the production of spirulina. The company has participated in a total of 3 deals. Its most recent funding round was a Series C raise of CNY 100 million in September 2011, led by CPE Funds Management, bringing the total amount raised to CNY 100 million.
The CEO of the company is Zhihong Yang. Yunnan Green A Biological Project Co. , Ltd. specializes in the production of high-quality spirulina, a blue-green algae known for its nutritional benefits.
The company's core offerings include bulk spirulina powder and tablets, which serve various health-focused markets, including dietary supplements and functional foods. These products cater to health-conscious consumers, fitness enthusiasts, and nutritional supplement companies looking to enhance their product lines with natural, nutrient-dense ingredients. The spirulina is cultivated under controlled conditions to ensure purity and quality, providing essential vitamins, minerals, and proteins that address various health concerns, such as boosting immunity and improving energy levels. The company's products are marketed not only in China but also in international markets, including North America and Europe, where demand for plant-based health supplements is increasing.
Yunnan Green A Biological Project Co. , Ltd. generates revenue through a combination of direct sales to consumers and B2B transactions with health food retailers and distributors. The company's flagship product, spirulina powder, is typically sold in bulk to businesses that incorporate it into their health products or sell it as a standalone supplement.
The pricing structure is designed to accommodate both small-scale health stores and larger distribution partners, allowing for flexibility in order sizes and pricing based on volume. This dual approach enables the company to establish long-term partnerships with retailers while also addressing the needs of individual consumers through direct sales channels. The transactional model emphasizes sustainable growth, as the company focuses on building a loyal customer base that values the health benefits and quality of their spirulina products. Yunnan Green A Biological Project Co.
, Ltd. aims to expand its product lines and markets in the coming years. Plans include the introduction of new spirulina-based products, with specific launch dates yet to be finalized. The company is targeting further expansion into international markets, especially in North America and Europe, by 2023.
The recent Series C funding of CNY 100 million will be utilized to support these initiatives and enhance production capabilities.
Current Investors
CPE Funds Management, China Science & Merchants Capital Management, IDG Capital
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements, Healthcare
Website
www.greena.com.cn
Company Stage
Series C
Total Amount Raised
Subscriber access only
Yunnan Green A Biological Project Co., Ltd. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.